Bisoprolol PCD Pharma Franchise Company

Cafoli Lifecare offers a Bisoprolol range of 15 tablet formulations, manufactured in WHO-GMP certified facilities. Distributors building a cardiovascular portfolio can secure district-wise monopoly franchise rights for this widely prescribed cardioselective beta-blocker with full promotional support.

What is Bisoprolol?

Bisoprolol is a highly cardioselective beta-1 adrenergic blocker. By reducing heart rate, cardiac workload and blood pressure, it is used to manage hypertension, angina and chronic stable heart failure, where it is one of the evidence-based beta-blockers shown to improve outcomes. Reference: MedlinePlus - Bisoprolol.

Available Forms

The Cafoli Bisoprolol portfolio is offered as oral Tablets across common strengths, including fixed-dose combinations with other antihypertensives. Contact us for current pack presentations and combinations.

Therapeutic Applications

Bisoprolol is prescribed for hypertension, chronic stable angina and chronic heart failure, and to control heart rate in various cardiac conditions. Prescribers include cardiologists, physicians and general practitioners managing cardiovascular disease.

Why Bisoprolol is a High-Potential Molecule for Distributors

Cardiovascular disease is among the leading disease burdens in India and beta-blocker therapy is lifelong, so bisoprolol generates highly predictable, month-after-month chronic refills. Its established role in both hypertension and guideline-based heart-failure therapy gives it a broad, stable prescriber base and reliable long-term volume for the distributor.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.

References

1. MedlinePlus: Bisoprolol
2. PubChem: Bisoprolol
3. WHO Essential Medicines List - bisoprolol